Skip to main content

Using the Eye as a Window into Earlier Dementia Risk

Blüm Health supported NeurEYE in translating advanced retinal imaging and AI research into a practical proof-of-concept application designed to explore how routine eye scans could help identify dementia risk earlier.

NeurEYE: Using AI and retinal imaging to support earlier dementia risk detection

Public innovation project | AI in healthcare | Retinal imaging | Brain health | Proof-of-concept app development

Blüm Health is supporting the NeurEYE project, a major public innovation initiative exploring how AI and retinal imaging could help identify dementia risk through routine eye tests.

Led by the University of Edinburgh in partnership with Glasgow Caledonian University, NeurEYE brings together data scientists, clinicians and optometrists to investigate whether retinal scans can provide earlier insight into neurodegenerative disease risk. The project is based on the connection between the retina and the brain, with retinal blood vessels and neural pathways offering a potentially accessible window into wider brain health.

Dementia is frequently diagnosed late, often after symptoms have progressed and opportunities for earlier intervention, treatment planning and support have been missed. NeurEYE is working to address this challenge by using artificial intelligence and machine learning to analyse retinal imaging data and identify patterns that could indicate a person’s risk of developing dementia.

The NeurEYE research team has collected close to one million retinal scans from optometrists across Scotland, forming one of the world’s largest datasets of its kind. This imaging data is linked, in anonymised form, to patient records covering factors such as demographics, treatment history and pre-existing conditions. The data is held securely within the Scottish National Safe Haven and governed through NHS Scotland data governance frameworks.

As part of the project, the University of Edinburgh awarded Blüm Health Ltd a contract to deliver a proof-of-concept wellness application using retinal image analysis to provide health insights. This work reflects Blüm’s ability to support early-stage digital health research and translate complex clinical and data science concepts into practical, user-facing technology.

NeurEYE is part of NEURii, a global collaboration involving pharmaceutical, philanthropic, health data and medical research organisations, focused on harnessing digital, data and AI innovation to improve care for people living with dementia and other neurodegenerative conditions.

Relevant capabilities

  • AI-enabled healthcare product development

  • Proof-of-concept health application development

  • Retinal imaging and brain health innovation

  • Digital tools for early risk identification

  • Health data and research translation

  • User-facing wellness and health insight applications

  • Secure, compliant digital health development

Read more about the Neureye Project on the BBC Website